JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266334

Human TWF2 knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

TWF2 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: 17 bp deletion in exon 3.

View Alternative Names

A6-related protein, A6RP, A6r, MSTP011, PTK 9L, PTK9L protein tyrosine kinase 9 like, Protein tyrosine kinase 9-like, TWF2_HUMAN, Twinfilin actin binding protein homolog 2, Twinfilin like protein, Twinfilin-1-like protein, Twinfilin-2, hA6RP

1 Images
Sanger Sequencing - Human TWF2 knockout HEK-293T cell line (AB266334)
  • Sanger seq

Unknown

Sanger Sequencing - Human TWF2 knockout HEK-293T cell line (AB266334)

Homozygous : 17 bp deletion in exon 3

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 17 bp deletion in exon 3

Product details

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266334-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266334 Human TWF2 knockout HEK-293T cell line", "number":"AB266334-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266334-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266334 Human TWF2 knockout HEK-293T cell line", "number":"AB266334-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
TWF2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Twinfilin-2 also known as TWF2 is a protein that plays a critical role in actin dynamics. It weighs approximately 40 kDa and is primarily expressed in skeletal muscle heart and brain tissues. TWF2 works as a member of the twinfilin family of proteins which are known for their ability to bind actin monomers and regulate actin filament assembly. Through its actin-binding properties TWF2 serves its functions effectively at the cellular level.
Biological function summary

Twinfilin-2 assists in the modulation of actin filament turnover acting as a cofilin homolog. TWF2 does not work alone; it forms part of a multi-protein complex that influences actin dynamics. It uniquely prevents actin polymerization which is vital for various cellular processes including cell motility and muscle contraction. The protein's action in actin turnover directly impacts cell shape and movement making it essential in maintaining the cellular cytoskeleton.

Pathways

Twinfilin-2 integrates into key signal transduction pathways involving actin cytoskeleton regulation. The protein interfaces with the Rho family of GTPases a group of proteins critical for controlling actin organization. TWF2 also interacts with proteins like cofilin and profilin to fine-tune actin filament dynamics contributing to both cell division and migration processes. This integration showcases its importance in cellular structural organization and signaling.

Alterations in twinfilin-2 expression or function have been linked to certain muscular and neurological disorders. For instance aberrant TWF2 activity can contribute to muscle dystrophies due to its role in actin dynamics. Additionally research indicates a relationship between TWF2 and huntingtin protein implicating it in Huntington's disease where disrupted actin homeostasis plays a role. Understanding these links can shed light on potential therapeutic targets for such conditions.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com